Tg(DMD-APP*)7Neve
Transgene Detail
|
Symbol: |
Tg(DMD-APP*)7Neve |
Name: |
transgene insertion 7, Rachel L Neve |
MGI ID: |
MGI:3720652 |
Synonyms: |
APP-C100, BetaAPP-C104 |
Transgene: |
Tg(DMD-APP*)7Neve Location: unknown
|
Alliance: |
Tg(DMD-APP*)7Neve page
|
|
Strain of Origin: |
(C57BL/6 x SJL)F2
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(DMD-APP*)7Neve expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
APP (351) |
|
The gene encodes the C terminal 100 amino acids. |
|
|
|
Mutation details: A fragment consisting composed of the sequence ot the terminal 100 amino acids of the beta-amyloid precursor protein (APP) gene (C104, referred to as C100 in J:100978 which states that the transgene contains the terminal 100 amino acids of APP) was inserted into a plasmid encoding the neural-specific dystrophin (DMD) promoter. The vector also contained the SV40 early splice and polyadenylation sequences. Several founder lines were identified, but line 7 was the most extensively characterized line. RT-PCR of tissues from 6-month old mice revealed predominant expression in the brain (>10-fold higher than in any other tissue where low level-transcription was detected).
(J:100978, J:105050)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:105050 Kammesheidt A, et al., Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10857-61 |
All: |
2 reference(s) |
|